Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban

Trial Profile

Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2017

At a glance

  • Drugs Prothrombin complex concentrate (Primary) ; Rivaroxaban (Primary) ; Tranexamic acid (Primary)
  • Indications Haemorrhage
  • Focus Pharmacodynamics
  • Sponsors Janssen Pharmaceuticals
  • Most Recent Events

    • 06 Nov 2017 Results published in the Journal of Thrombosis and Haemostasis
    • 04 Jul 2016 Status changed from recruiting to completed.
    • 02 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top